Curis, Inc. (NASDAQ:CRIS) Q2 2023 Earnings Call Transcript
Operator: Good afternoon and welcome to the Curis’ Second Quarter 2023 Business Update Call. All participants will be in a listen-only mode.
Posts Tagged ‘NASDAQ:CRIS’
Curis, Inc. (NASDAQ:CRIS) Q1 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the Curis First Quarter 2023 Business Update Call. Please note, this event is being recorded.
Curis, Inc. (NASDAQ:CRIS) Q4 2022 Earnings Call Transcript
Operator: Good morning, and welcome to the Curis Fourth Quarter 2022 Business Update Call. Please note, this event is being recorded.
5 Stocks to Invest In Under $20 According to Michael Castor’s Sio Capital
In this piece, we will take a look at the five stocks to invest in under $20 according to Sio Capital.
5 Best Biotech Stocks Under $5
Agenus Inc. (NASDAQ:AGEN) is a clinical-stage immuno-oncology company based in Lexington, Massachusetts.
10 Healthcare Stocks to Buy According to Lee Ainslie’s Maverick Capital
In this piece, we will take a look at the ten healthcare stocks to buy according to Lee Ainslie's Maverick Capital.
Do Hedge Funds Love Curis, Inc. (CRIS)?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
5 Best Healthcare Stocks Under $20 According to Michael Castor’s Sio Capital
In this article, we discuss the 5 best healthcare stocks under $20 according to Michael Castor's Sio Capital.
10 Pharmaceutical Stocks to Buy Today According to Tiger Cub Billionaire Lee Ainslie
In this article, we will take a look at 10 pharmaceutical stocks to buy today according to Tiger Cub Billionaire Lee Ainslie.
Hedge Funds Have Never Been This Bullish On Curis, Inc. (CRIS)
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade.
Is CRIS A Good Stock To Buy Now?
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity...
Do Hedge Funds Love Curis, Inc. (CRIS)?
In this article you are going to find out whether hedge funds think Curis, Inc. (NASDAQ:CRIS) is a good investment right now.
Should You Buy Curis, Inc. (CRIS)?
We can judge whether Curis, Inc. (NASDAQ:CRIS) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas.
Capstone Turbine Corporation (CPST) and Seadrill Ltd (SDRL) Among Hedge Funds’ Favorite Penny Stocks
New and inexperienced investors are usually advised to stick to index funds, or ETFs at the beginning, and if they want to venture into individual stocks they should look at value...
Hedge Funds Are Selling Curis, Inc. (CRIS)
Hedge fund managers like David Einhorn, Dan Loeb, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock picks...
Vista Outdoor Inc (VSTO), Curis, Inc. (CRIS): First Eagle Investment Management’s Latest Bullish Plays
Jean-Marie Eveillard's First Eagle Investment Management has recently disclosed two moves involving Vista Outdoor Inc (NYSE:VSTO), and Curis, Inc. (NASDAQ:CRIS).
Progenics Pharmaceuticals, Inc. (PGNX): Insiders Aren’t Crazy About It But Hedge Funds Love It
To the average investor, there are tons of indicators shareholders can use to watch publicly traded companies.
Here is What Hedge Funds Think About Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)
At the moment, there are tons of metrics shareholders can use to monitor their holdings. A couple of the most under-the-radar are hedge fund and insider trading sentiment.
Hedge Funds Are Selling Threshold Pharmaceuticals, Inc. (THLD)
At the moment, there are tons of methods market participants can use to watch Mr. Market. A pair of the most useful are hedge fund and insider trading sentiment.
Curis, Inc. (CRIS), Bristol Myers Squibb Co. (BMY), Novartis AG (ADR) (NVS): Can Stopping This Hedgehog Create New Cancer Treatments?
Curis, Inc. (NASDAQ:CRIS) and Roche Holding Ltd.
Is Coronado Biosciences Inc (CNDO) Going to Burn These Hedge Funds?
If you'd ask most market participants, hedge funds are viewed as worthless, old financial vehicles of years past.
Should You Avoid GTx, Inc. (GTXI)?
Is GTx, Inc. (NASDAQ:GTXI) a superb investment right now? Investors who are in the know are taking a pessimistic view.
This Metric Says You Are Smart to Buy Curis, Inc. (CRIS)
Curis, Inc. (NASDAQ:CRIS) was in 10 hedge funds' portfolio at the end of March. CRIS investors should be aware of an increase in hedge fund interest in recent months.
Do Hedge Funds and Insiders Love Cerus Corporation (CERS)?
In today’s marketplace, there are a multitude of indicators market participants can use to watch stocks.
Should You Buy Progenics Pharmaceuticals, Inc. (PGNX)?
Is Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) a worthy investment now? Prominent investors are taking an optimistic view.
Hedge Funds Are Betting On Cerus Corporation (CERS)
To most traders, hedge funds are viewed as slow, outdated investment tools of the past.
Is Curis, Inc. (CRIS) Going to Burn These Hedge Funds?
Curis, Inc. (NASDAQ:CRIS) was in 6 hedge funds' portfolio at the end of the fourth quarter of 2012.
